1 | forceris home coccidiosis iron | | | | | | | 1 | 0.45% |
2 | injection forceris™ prevents iron | | | | | | | 1 | 0.45% |
3 | exit forcerisx2122 the first | | | | | | | 1 | 0.45% |
4 | forcerisx2122 the first registered | | | | | | | 1 | 0.45% |
5 | injectable combination of gleptoferron | | | | | | | 1 | 0.45% |
6 | combination of gleptoferron and | | | | | | | 1 | 0.45% |
7 | of gleptoferron and toltrazuril | | | | | | | 1 | 0.45% |
8 | gleptoferron and toltrazuril in | | | | | | | 1 | 0.45% |
9 | and toltrazuril in one | | | | | | | 1 | 0.45% |
10 | toltrazuril in one single | | | | | | | 1 | 0.45% |
11 | forceris™ prevents iron deficiency | | | | | | | 1 | 0.45% |
12 | regulations enter exit forcerisx2122 | | | | | | | 1 | 0.45% |
13 | prevents iron deficiency anaemia | | | | | | | 1 | 0.45% |
14 | iron deficiency anaemia and | | | | | | | 1 | 0.45% |
15 | deficiency anaemia and coccidiosis | | | | | | | 1 | 0.45% |
16 | an innovative formulation opening | | | | | | | 1 | 0.45% |
17 | innovative formulation opening a | | | | | | | 1 | 0.45% |
18 | formulation opening a bright | | | | | | | 1 | 0.45% |
19 | opening a bright future | | | | | | | 1 | 0.45% |
20 | a bright future for | | | | | | | 1 | 0.45% |
21 | enter exit forcerisx2122 the | | | | | | | 1 | 0.45% |
22 | national regulations enter exit | | | | | | | 1 | 0.45% |
23 | future for piglets farmers | | | | | | | 1 | 0.45% |
24 | requirements users should consult | | | | | | | 1 | 0.45% |
25 | completeness of the information | | | | | | | 1 | 0.45% |
26 | of the information contained | | | | | | | 1 | 0.45% |
27 | the information contained or | | | | | | | 1 | 0.45% |
28 | information contained or its | | | | | | | 1 | 0.45% |
29 | contained or its compliance | | | | | | | 1 | 0.45% |
30 | or its compliance with | | | | | | | 1 | 0.45% |
31 | national regulatory requirements users | | | | | | | 1 | 0.45% |
32 | regulatory requirements users should | | | | | | | 1 | 0.45% |
33 | users should consult the | | | | | | | 1 | 0.45% |
34 | that complies with applicable | | | | | | | 1 | 0.45% |
35 | should consult the local | | | | | | | 1 | 0.45% |
36 | consult the local site | | | | | | | 1 | 0.45% |
37 | home coccidiosis iron deficiency | | | | | | | 1 | 0.45% |
38 | their countries to obtain | | | | | | | 1 | 0.45% |
39 | countries to obtain information | | | | | | | 1 | 0.45% |
40 | to obtain information that | | | | | | | 1 | 0.45% |